Member Info for Vanilla

Fair point actually having read posts again m44's last purchase was at 4.6p and not an average but still, buying at these prices will do wonders for your average.

M44 I understand your reservations about the BoD as I held shares through all of that and inspite of those clangers have bought more to lower my average to what I thought was a decent price. Like many though I'm still at a considerable loss with this continual decline in the sp and like some have mentioned your average is outstanding. My additional buying has coincided with significant purchases from OAM and other major shareholders including by BoD's. So not withstanding your point about the previous errors with all this buying who is it that is deciding that because of this mistrust of the BoD the sp should be 4.5p. Maybe it is due to a small percentage of shares not held by lth's that have all been sold so effectively the price is hammered by a small numer of traders. Since the announcement of achieving 230MeV which was supposed to be a major turning point the sp action looks very suspicious unless we hear bad news to back it up and justify what has happened on the surface it appears as pure manipulation but I'm sure all will be revealed.

Fair analysis M44 but don't you think it strange that with no major shareholders be it Directors or II's appearing to have off loaded their shares and infact have purchased more through fund raises that the sp has collapsed through the floor. This has also followed what was hotly anticipated as breakthrough news with achieving 230MeV.
Sometimes these drops are justified but I'm struggling to see the evidence here unless bad news was leaked that we are yet to hear. It looks like many PI's bought in advance of the major technical achievement and have now been robbed. Even the requirement for substantial additional funding doesn't justify what has happened.
I'm hoping there hasn't been a delay in the construction of the patient treatment area required at Daresbury so that this next important step can continue. Successful patient treatment/testing is the next significant milestone that no doubt will further demolish the sp if the trend continues. Dread to think what would happen if avo also manage to sign contracts for many of the 20 or so prospects in current negotiations!!!

I believe you are correct graking and cpx do have market leading edge technology in the prizmatic range of supercapacitors. I would say they pretty much sell themselves with their unique applications and characteristics. As the IoT market grows the orders will grow with it. The current orders consisting of signing up ex murata customers is what was expected and not what I'd call opening up new markets with a proactive sales team.
The large cap products however are a different story and I believe Jeff C was heavily involved in their development at Ioxus. This is where he needs to be earning his money in addition to increasing the sales of the prizmatic products. So far to date he and the rest of the team are failing miserably but that's not to say they aren't equipped with a very good range of products. When the market starts booming they'll be successful regardless, lets hope they don't just go banging on about a 100m pipeline as that doesn't pay the bills need to focus on the orderline. In fact I'd bung up the pipeline so they can stop wasting time filling it and concentrate on pulling them out the other end as orders!!!

It certainly is Jeff C & the rest of the sales team should be embarrassed compared to the success over at skeleton. My expectation is that once the market gets moving cpx will benefit inspite of their abysmal sales performance. They'll be ok at taking orders just don't seem to be able to sell anything. Lucky for us the market should recover and cpx with it.

I'm not sure we'll see customer deposits before any patient treatment takes place even then without a concrete timescale for accreditation it will be difficult to obtain customer deposits. I'd love to be wrong and the share price would fly if customers starting handing over cash. If that machine truly does what has been claimed it will be commercialised by someone. They just need this funding at acceptable terms to preserve shareholder value. It just doesn't seem right that the market can turn the news of achieving 230MeV into this mess but the dark forces operating in AIM seems to have managed it. If the sp rallied on the back of 230MeV there would have been a bit of a stampede making funding much easier. This rocky journey looks like it will continue throughout this year so will need stamina and grit to sit through it. Obviously the risk is much greater after this huge drop but equally you have to think the potential gains could be as huge if not greater....only time will tell.

Before anyone says should read 'should have' phone keeps changing words hopefully it will magically change the sp.

If you think this is risky now you should of been here a few years ago Stan. Seriously though if you've followed the story achieving 230MeV is a really significant derisking event.
The sp reaction after this news has caught them by surprise and made financing more difficult than it should of been. One of the real negatives of this AIM market where some take delight in trying to destroy worthwhile projects and achievements such as this.
Good news regarding the potential 15m available hope it brings about a sense of calm and stability so that proper negotiations can take place to secure a longer term more favourable financial package. This issue has unfortunately become a greater risk than all the previous technical uncertainties.
Feel much better this evening having digested todays news and continue to believe they will achieve success hopefully the dilution will allow some profit for holders not fortunate enough to have shares at these bargain prices.

Have to agree and this will provide the time required to secure the funds as outlined in the operational update. It's obviously not a simple exercise in the current climate but looks more likely than not to be secured. We've been here before it's not nice but being so far technically advanced this time it's difficult to see how they won't get this done.
Wasn't expecting such a tense nervous run up to the finish line it's never easy hopefully in the 2nd half of this year we'll be looking back at this sitting at a much higher sp.

It's difficult to know what's going on wallace4, unfortunately at face value the sp should be much higher and this massive fall is destroying confidence. A statement from the BoD would be welcome but I'm not sure we'll hear anything until they've sorted the finance out and where we'll be after that is impossible to know. I'm sure Odey have been in touch to ask what is going on the sooner we all know the better.
It just looks like the market makers drop the price for no obvious reason which generates some selling/buying interest but always leaves the sp lower.

Should read 'not expecting'. Regarding silence we did get a comprehensive update that laid out quite cleary what is required. I can imagine lots is going on to tie up the required funds and until it is in place there's probably not much else to say.

Good point meldrew I recall one of the presentations mentioning other applications but with the focus on delivering a working machine for cancer treatment didn't give it the recognition it probably deserves.
The main concern at present is whatever finance is arranged doesn't wipe out small PI's. I realise it will affect all shareholders including directors & institutions but they may be looked after within any arrangement although I'm expecting that to be the case and we all get a fair and reasonable outcome.

I know max it's been a rough journey you could decribe as a complete mess but one way or another they keep finding the funds. Now possibly just a few months away from patient treatment and visible evidence of a fully assembled and working machine the sp looks as if the complete opposite is true and that news of total failure is due.
This AIM market leaves much to be desired if it does fail then the market is reading it correctly but if they succeed you've got to question what's going on here in what could potentially destroy such a worthwhile technical achievement. Not much we can do other than wait for the announcement which one way or another will either cement the poor opinion of the BoD many have or restore their reputation and allow this project to progress to completion. Hopefully won't be going down with the Titanic and news will arrive soon. I'm not buying anymore and will continue to hold to what is looking like to the very end!

Not entirely true particularly in the biotech sector although the current sp is supporting your theory.
The potential benefit of Light especially Flash technology to this sector is huge. To be able to treat a wide range of cancers in a single Flash treatment will be an incredible achievement.
If you look at the values of biotech companies in early phase cancer drug development showing some promise they are significantly higher than avo yet years away from commercialisation. The development of these drugs is massively complex and takes years and years with regulatory approval just as long winded. The drugs are also often targeted to very specific cancer types so will not be of use to many other unfortunate cancer sufferers.
Having a machine like Avo's Light to compliment these treatments and be able to zap tumours with reduced side effects from collateral radiation damage will be a great advancement in the overall effort to improve the treatment of cancer.
The additional financing is going to incur some short term damage to the sp but once they get through this hurdle to the other side the future could and should be very promising. There will be not be a single cure for cancer but many improving complimentary treatments that allow for longer term survival and better quality of life for cancer sufferers. Light is one such treatment that needs to succeed so the sooner the funding is dealt with the better so that they can push on with patient treatment and regulatory approval. The market will then sort itself out and be substantial, shame it's not as forwards looking as with drug development but this is new groundbreaking stuff that the market doesn't appear to value correctly at present.

Well said u89 I didn't realise how the patients practically had zero hope/chance of benefitting from this trial with most not even having a type of disease that would normally be treated with dox. Some lunatics on the other BB were claiming that this would be headline news on the BBC with miracle cures announced if it was going well and as expected just trying to scaremonger. Now you see the detail of what's involved in the trials you understand AS's carefully chosen words to explain progress and how long the process is.
Even for the soon to begin next phase as mentioned in the presentation patients will have to chose between being given a known to help course of dox or AVA6000 which may or may not work better. The good thing for the patients who chose AVA6000 is that at least without DLT's they still could be given straight dox if for whatever reason their type of disease did not respond well to AVA6000. Let's hope for a good outcome for all involved and the resulting improving sp will be pleasing for all the right reasons.

Well having watched a bit more of the presentation in particular Andrew Saunders and Dr Tam I'd be amazed if we don't see substantial progress in the US. The size of some of the trials Dr Tam discussed involving over 600 patients worldwide could be where AVA6000 is heading and no doubt nasdaq funding or involvement with a major company being a distinct possibility.
One simplified view from the SD is that this is no cure for cancer which is not going away. There are a multitude of cancer types and many types of treatments that will coexist for years to come. Some of the claims I've read of other treatments superior efficacy and advanced development in no way reflects the complexity of the problem. These treatments are highly specific and targeted to a unique set of circumstances.
Dox is one such treatment and has been around for 50yrs so is well understood and works very effectively for the types of cancer it is used to treat. Unfortunately due to toxicity it is limited to the length of time it can be used and the types of patient it can be administered to therefore only extends patients lives for up to around 24 months as the cancer returns.
You can see a scenario of not only significantly more patients being able to be treated with AVA6000 but also it's continued use as an ongoing treatment for the life of each patient to keep the cancer under control.
This will massively increase the market for dox which I understand is around $1.5B.
Dr Tam came across as really motivated to progress the development of soft tissue sarcoma STS treatment with dox in a modified improved form such as AVA6000 even suggesting such a treatment could become the 'standard of care' overnight!
He didn't just come to the SD to present some slides, he's taking this to the US to run with the next phase of the trial at a much greater and significant level. There is still a long way to go and much work to be carried out but if phase 2 progresses in this way with the significance of who is involved and potential size of the trials the value of AVA6000 will be set inline with other similar deals that we all know about courtesy of information already provided by well informed posters.

Good luck max, against my better judgement I too finally bought some more yesterday, not quite got down to your average but it's getting lower. Hopefully we all make something out of this after so long or at the very least get our money back.

The previous 25p placings with all the outstanding warrants was valuing avo at around 200m which seemed reasonable. They can't issue shares below 25p so the current situation is concerning and creates much uncertainty around future funding. The current sp in no way reflects the progress made based on the recent operational update unless something has changed that we are not aware of but you'd think the last director purchases were intended to alleviate any concerns. As things stand with what is known once funds are secured you would expect it to be at a value reflecting the true worth and not based on a beaten down sp due to the aim scaremongering brigade. I'm sure they're trying to nail this down asap and we'll get an update when it's concluded.

Driving I agree and with your predicted valuation of 2 to 300m. I've been holding for years and your recent purchases have resulted in you exceeding my total with a far lower average so congrats to you and anyone else buying at what seems like bargain basement prices. Hopefully you, I and all other holders will be rewarded when this current difficult financing situation is resolved.

I'm not sure the 8.3p equation for the last raise is correct as they have to purchase each warrant for 25p so 1 share plus 2 warrants would cost 75p.
Good luck to everyone buying at this ridiculously low sp wish I could justify releasing some cash to join in makes my 22p last purchase annoying to say the least could have had 3x more shares.
After the amazing news of 230MeV can't believe the sp is this low still think the assets and IP are worth in excess of £200m. If all is progressing as per the last update it can only be as a result of the aim vultures preying on the huge uncertainty of raising finance. No doubt it will be dilutive but if raised and progress towards accreditation continues should patient treatment be successful the potential sp gains from here you'd think would be significant.